Dice Therapeutics, Inc.
Dice Therapuetics, Inc. is a San Francisco-based biopharmaceutical company that develops medicines for chronic autoimmune and inflammatory diseases. The company was acquired by Eli Lily in August 2023.
Acquisition Transaction
Also Known As
DiCE MOLECULES HOLDINGS, LLC
CEO
CIK Number
Legal Name
DICE Therapeutics, Inc.
Company Operating Status
Active
Country
Crunchbase URL
Email Address
info@dicetx.com
0
katie@1abmedia.com
0
Fax Number
650.566.1429
Founded Date
2013
0
Founder
Full Address
400 East Jamie Court, Third Floor South San Francisco, CA 94080, USA
0
Industry
IRS Number
47
0
Latest Funding Round Date
2021
Latest Funding Round Amount (USD)
60,000,000
Latest Funding Type
Legal classification
LinkedIn URL
Number of Employees (Ranges)
51 – 200
Phone Number
+16505661402
Pitchbook URL
Place of Incorporation
Previous Name
DiCE Molecules Holdings, LLC
0
Public/Private
Public
0
SIC Code
2,834
0
Exchange
Stock Symbol
DICE
0
Ticker Symbol
DICE
Total Funding Amount (USD)
140,000,000
Official Website
Find more companies like Dice Therapeutics, Inc.
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.